Drug
Levoleucovorin clinical trials
Includes 6 studies of Levoleucovorin calcium.
Keep track of what changes. Save the Levoleucovorin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
14 studies that test it; most in 2013 (3)
| Year | Studies |
|---|---|
| 1997 | 1 |
| 2002 | 2 |
| 2005 | 1 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2020 | 2 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 6
Southwest Autism Research & Resource Center (2) · Takeda (2) · Wyeth is now a wholly owned subsidiary of Pfizer (2) · Acrotech Biopharma Inc. (2) · Eli Lilly and Company (1) · Institute of Cancer Research, United Kingdom (1) · Suzhou Suncadia Biopharmaceuticals Co., Ltd. (1) · Gruppo Oncologico del Nord-Ovest (1)
Often tested with
Tested in the same studies.
Fluorouracil (7) · Oxaliplatin (5) · Panitumumab (2) · Bevacizumab (2) · Irinotecan (2) · Pralatrexate (2) · Ramucirumab (1) · Trastuzumab rezetecan (1)
Studies
Open first, then newest update. How each study uses Levoleucovorin is read from its arms, and is right about nine times in ten.
Testing it · 14
- A Clinical Study of SHR-A1811 in Combination With Chemotherapy and Bevacizumab Versus Standard Therapy as First-Line Treatment for Advanced Colorectal CancerRecruitingPhase 3Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT07676162Written as SHR-A1811, Oxaliplatin, Levo-leucovorin, Fluorouracil and Bevacizumab
- Treatment of Social and Language Deficits With Leucovorin for Young Children With AutismRecruitingPhase 2Southwest Autism Research & Resource CenterNCT04060030Written as Levoleucovorin Calcium
- Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin CalciumActive, not recruitingPhase 2Southwest Autism Research & Resource CenterNCT04060017Written as Levoleucovorin Calcium
- Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer PatientsSuspendedPhase 2Gruppo Oncologico del Nord-OvestNCT05062889Written as L-Leucovorin
- Panitumumab and RAS, Diagnostically-useful Gene Mutation for mCRCCompletedPhase 3TakedaNCT02394795Written as oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab
- Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Folotyn®WithdrawnPhase 1Acrotech Biopharma Inc.NCT01820091Written as Fusilev
- Phase 1 Study of Fusilev to Prevent or Reduce Mucositis in Patients With Non-Hodgkin's Lymphoma Receiving FolotynWithdrawnPhase 1Acrotech Biopharma Inc.NCT01789723Written as Fusilev
- Safety and Efficacy Study of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Participants With Chemotherapy-naïve Unresectable Advanced Recurrent Colorectal CarcinomaCompletedPhase 2TakedaNCT02337946Written as oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab
- Comparing HAI-90Y (SIR-spheres)+Chemotx LV5FU2 Versus Chemotx LV5FU2 Alone to Treat Colorectal CancerStatus unknownPhase 3Universiteit AntwerpenNCT01895257Written as systemic chemotherapy LV5FU2
- A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)CompletedPhase 1Eli Lilly and CompanyNCT01286818Written as levofolinate
- Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically RemovedCompletedPhase 3Institute of Cancer Research, United KingdomNCT00005586Written as L-leucovorin
- Study Evaluating Isovorin in Advanced/Recurrent Gastric CancerCompletedPhase 3Wyeth is now a wholly owned subsidiary of PfizerNCT00195572Written as Isovorin
- Study Evaluating Isovorin in Colon CancerCompletedPhase 3Wyeth is now a wholly owned subsidiary of PfizerNCT00195585Written as Isovorin
- Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal CancerTerminatedPhase 2Hokkaido Gastrointestinal Cancer Study GroupNCT00209703Written as l-Leucovorin
Given in every arm · 46 — Levoleucovorin is usual care beside what is tested
- Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged LeukemiaRecruitingPhase 2National Cancer Institute (NCI)NCT06317662Written as Levoleucovorin
- FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II)Not yet recruitingPhase 2Sun Yat-sen UniversityNCT07621497Written as Levofolinic Acid For Injection
- Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)RecruitingPhase 1/2Merck Sharp & Dohme LLCNCT06780111Written as Levoleucovorin
- A Study of Olomorasib (LY3537982) in Participants With Advanced Colorectal Cancer and a KRAS G12C MutationNot yet recruitingPhase 2Eli Lilly and CompanyNCT07814417Written as Leucovorin/levofolinate calcium
- Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)RecruitingPhase 1/2Merck Sharp & Dohme LLCNCT06469944Written as Levoleucovorin
- A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)RecruitingPhase 3Merck Sharp & Dohme LLCNCT06997497Written as Leucovorin/levofolinate calcium
- AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2RecruitingPhase 2AstraZenecaNCT06219941Written as l-leucovorin
- A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received ChemotherapyRecruitingPhase 3Janssen Research & Development, LLCNCT06750094Written as Leucovorin calcium/Levoleucovorin
- A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal CancerRecruitingPhase 3Janssen Research & Development, LLCNCT06662786Written as Leucovorin calcium/Levoleucovorin
- A Trial of ONO-4578 Versus Placebo in Combination With Nivolumab and Chemotherapy in Participants With Gastric Cancer, Esophagogastric Junction Cancer, or Esophageal AdenocarcinomaNot yet recruitingPhase 3Ono Pharmaceutical Co., Ltd.NCT07818070Written as Levoleucovorin
- A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal CancerRecruitingPhase 3Seagen, a wholly owned subsidiary of PfizerNCT05253651Written as levoleucovorin
- An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction AdenocarcinomaRecruitingPhase 2National Cancer Center Hospital EastNCT07018570Written as Levofolinate
- Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction AdenocarcinomaRecruitingPhase 3Fujian Cancer HospitalNCT06793917Written as Levo-Leucovorin
- Phase I/II Study of the Combination of Irinotecan and POF (POFI) and TislelizumabRecruitingPhase 1/2Fujian Cancer HospitalNCT05319639Written as Levo-Leucovorin
- Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal CancerRecruitingPhase 3National Cancer Institute, NaplesNCT06509126Written as L-folinic acid
- Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric CancerNot yet recruitingPhase 2Fujian Cancer HospitalNCT06197438Written as Levo-Leucovorin
- Study of ONO-4578 and XELOX/FOLFOX Plus Bevacizumab in Colorectal CancerActive, not recruitingPhase 1Ono Pharmaceutical Co., Ltd.NCT06547385Written as Calcium Levofolinate Hydrateb
- An Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic CancerActive, not recruitingPhase 1Ono Pharmaceutical Co., Ltd.NCT06532344Written as Levofolinate
- The Study of ONO-7913, ONO-4538 and the Standard of Care as First-line Treatment in Patients Colorectal CancerActive, not recruitingPhase 1Ono Pharmaceutical Co., Ltd.NCT06540261Written as Levofolinate
- Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaActive, not recruitingPhase 3Children's Oncology GroupNCT03007147Written as Levoleucovorin
Showing 20 of 46.
As the comparator · 7 — what is tested is compared with Levoleucovorin
- A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy FailureRecruitingPhase 3Sichuan Baili Pharmaceutical Co., Ltd.NCT07606599Written as Calcium levofolinate
- A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy(PANKU-BTC01)RecruitingPhase 3Sichuan Baili Pharmaceutical Co., Ltd.NCT07582315Written as Calcium levofolinate
- Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)CompletedPhase 3Merck Sharp & Dohme LLCNCT04456699Written as Leucovorin/ levoleucovorin
- Phase II of BAX2398/5-FU/Calcium Levofolinate in Pancreatic CancerCompletedPhase 2Institut de Recherches Internationales ServierNCT02697058Written as 5-FU/calcium levofolinate
- PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon CancerCompletedPhase 1/2Isofol Medical ABNCT01681472Written as Levoleucovorin 200 mg/m2
- A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)CompletedPhase 3Haruhiko FukudaNCT00190515Written as 5FU+l-leucovorin
- IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal CancerSuspendedPhase 3Hokkaido Gastrointestinal Cancer Study GroupNCT00316745Written as Isovorin
Codes
What other systems call Levoleucovorin · ClinicalTrials.gg INT008929
- MeSH (NLM) D058766LevoleucovorinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 990S25980YLEVOLEUCOVORINConfirmed FDA, NLM
- RxNorm 877015One source FDA
- NCI Thesaurus C1559LevoleucovorinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D058766 | Levoleucovorin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 990S25980Y | LEVOLEUCOVORIN | Confirmed FDA, NLM |
| RxNorm | 877015 | — | One source FDA |
| NCI Thesaurus | C1559 | Levoleucovorin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.